Syntekabio and Enamine partner for AI-based drug development
The companies will work together at the AI Bio Supercomputer Center in Daejeon.
Artificial Intelligence
How AI can help tackle the challenges of precision and personalised medicine
How clinical trials can use AI responsibly and effectively
Rejuvenate and SAS partner to harness AI for age-related diseases
How NVIDIA grew with the healthcare market instead of pushing into it
CytoReason secures $80m investment for AI expansion
Capturing the genAI boom for drug development
Lilly joins fellow pharma giants in OpenAI partnership
